You just read:

Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013

News provided by

Volcano Corporation

23 May, 2013, 09:55 BST